Opinion

Video

Optimal Strategies for Bridging Therapy for Patients Receiving CAR T in Early R/R MM

Panelists discuss their optimal strategies for bridging therapy when preparing patients to receive chimeric antigen receptor (CAR) T in the treatment of relapsed/refractory multiple myeloma (R/R MM).

Related Videos
5 experts are featured in this series
5 experts are featured in this series
Pooja Phull, MD
2 expert is featured in this series.